2013 年冠状动脉疾病的支架或手术。
Stents or surgery in coronary artery disease in 2013.
机构信息
Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, Oxford, UK.
出版信息
Ann Cardiothorac Surg. 2013 Jul;2(4):431-4. doi: 10.3978/j.issn.2225-319X.2013.07.20.
Abstract
In addition to optimal medical therapy, some patients with coronary artery disease also require intervention on symptomatic and/or prognostic grounds. The debate over the relative efficacies of coronary artery bypass grafting (CABG) and stenting has recently been settled by the publication of the five-year outcomes of the SYNTAX and FREEDOM (in patients with diabetes) trials accompanied by supportive data from several large registries. There is also current evidence that stenting is still carried out in patients who would be better served by CABG, emphasizing the need for recommendations for intervention to be overseen by a multidisciplinary team rather than the individual practitioner.
摘要
除了最佳的医学治疗外，一些患有冠状动脉疾病的患者还需要根据症状和/或预后进行干预。最近，SYNTAX 和 FREEDOM（糖尿病患者）试验的五年结果的公布解决了冠状动脉旁路移植术（CABG）和支架置入术的相对疗效的争议，并伴有来自几个大型注册中心的支持数据。目前还有证据表明，即使在 CABG 治疗效果更好的患者中，仍在进行支架置入术，这强调了干预建议应由多学科团队而不是个别医生监督。
相似文献
1
Stents or surgery in coronary artery disease in 2013.2013 年冠状动脉疾病的支架或手术。
Ann Cardiothorac Surg. 2013 Jul;2(4):431-4. doi: 10.3978/j.issn.2225-319X.2013.07.20.
2
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.冠状动脉旁路移植术与经皮冠状动脉介入治疗支架置入治疗冠状动脉疾病的死亡率：一项个体患者数据的合并分析。
Lancet. 2018 Mar 10;391(10124):939-948. doi: 10.1016/S0140-6736(18)30423-9. Epub 2018 Feb 23.
3
CABG in 2012: Evidence, practice and the evolution of guidelines.2012年的冠状动脉旁路移植术：证据、实践与指南的演变
Glob Cardiol Sci Pract. 2013 Nov 1;2012(2):21-8. doi: 10.5339/gcsp.2012.20. eCollection 2012.
4
Impact of SYNTAX Score on 10-Year Outcomes After Revascularization for Left Main Coronary Artery Disease.SYNTAX 评分对左主干冠状动脉疾病血运重建后 10 年结局的影响。
JACC Cardiovasc Interv. 2020 Feb 10;13(3):361-371. doi: 10.1016/j.jcin.2019.10.020.
5
Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries.SYNTAX 经皮冠状动脉介入治疗和冠状动脉旁路移植术嵌套注册研究的风险特征和 3 年结果。
JACC Cardiovasc Interv. 2012 Jun;5(6):618-25. doi: 10.1016/j.jcin.2012.02.013.
6
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.冠状动脉血运重建术后卒率比较：外科手术与经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.
7
Long-Term (10-Year) Outcomes of Stenting or Bypass Surgery for Left Main Coronary Artery Disease in Patients With and Without Diabetes Mellitus.左主干冠状动脉疾病伴或不伴糖尿病患者支架置入或旁路手术的 10 年长期结局。
J Am Heart Assoc. 2020 Apr 21;9(8):e015372. doi: 10.1161/JAHA.119.015372. Epub 2020 Apr 20.
8
Management of acute coronary syndromes in patients with diabetes: implications of the FREEDOM trial.糖尿病患者急性冠脉综合征的管理：FREEDOM 试验的启示。
Clin Ther. 2013 Aug;35(8):1069-75. doi: 10.1016/j.clinthera.2013.07.427.
9
Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes.左主干病变伴糖尿病患者行旁路移植术或支架置入术治疗的比较
J Am Coll Cardiol. 2019 Apr 9;73(13):1616-1628. doi: 10.1016/j.jacc.2019.01.037.
10
Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.多支血管病变和/或无保护左主干病变患者行冠状动脉支架置入术或旁路移植术的个体长期死亡率预测：SYNTAX II 评分模型在 BEST 和 PRECOMBAT 随机对照试验 1480 例患者中的外部验证。
JACC Cardiovasc Interv. 2016 Aug 8;9(15):1564-72. doi: 10.1016/j.jcin.2016.04.023.
引用本文的文献
1
Genetics, coronary artery disease, and myocardial revascularization: will novel genetic risk scores bring new answers?遗传学、冠状动脉疾病与心肌血运重建：新型遗传风险评分会带来新答案吗？
Indian J Thorac Cardiovasc Surg. 2018 Dec;34(Suppl 3):213-221. doi: 10.1007/s12055-017-0635-6. Epub 2018 Jan 18.
2
Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in people with coronary artery disease.经桡动脉与经股动脉途径用于冠心病患者的诊断性冠状动脉造影及经皮冠状动脉介入治疗
Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD012318. doi: 10.1002/14651858.CD012318.pub2.
3
Guidelines versus reality: is coronary stent application in three-vessel disease standard or the exception?指南与现实：三血管病变中冠状动脉支架应用是标准还是例外？
Eur J Health Econ. 2018 Jul;19(6):821-830. doi: 10.1007/s10198-017-0924-4. Epub 2017 Aug 19.
4
A systematic review on robotic coronary artery bypass graft surgery.机器人辅助冠状动脉旁路移植手术的系统评价
Ann Cardiothorac Surg. 2016 Nov;5(6):530-543. doi: 10.21037/acs.2016.11.08.
本文引用的文献
1
2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).2014 欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南：欧洲心脏病学会（ESC）和欧洲心胸外科学会（EACTS）心肌血运重建特别工作组。由欧洲经皮心血管介入协会（EAPCI）提供特别贡献制定。
Eur J Cardiothorac Surg. 2014 Oct;46(4):517-92. doi: 10.1093/ejcts/ezu366. Epub 2014 Aug 29.
2
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.冠状动脉旁路移植术与经皮冠状动脉介入治疗在三支病变合并左主干病变患者中的比较：随机、临床 SYNTAX 试验的 5 年随访结果。
Lancet. 2013 Feb 23;381(9867):629-38. doi: 10.1016/S0140-6736(13)60141-5.
3
Strategies for multivessel revascularization in patients with diabetes.多血管血运重建策略在糖尿病患者中的应用。
N Engl J Med. 2012 Dec 20;367(25):2375-84. doi: 10.1056/NEJMoa1211585. Epub 2012 Nov 4.
4
Comparative effectiveness of revascularization strategies.血运重建策略的比较效果。
N Engl J Med. 2012 Apr 19;366(16):1467-76. doi: 10.1056/NEJMoa1110717. Epub 2012 Mar 27.
5
Long-term mortality of coronary artery bypass grafting and bare-metal stenting.冠状动脉旁路移植术和金属裸支架的长期死亡率。
Ann Thorac Surg. 2011 Dec;92(6):2132-8. doi: 10.1016/j.athoracsur.2011.06.061. Epub 2011 Oct 19.
6
Appropriateness of percutaneous coronary intervention.经皮冠状动脉介入治疗的适宜性。
JAMA. 2011 Jul 6;306(1):53-61. doi: 10.1001/jama.2011.916.
7
Informed consent for interventions in stable coronary artery disease: problems, etiologies, and solutions.稳定型冠状动脉疾病干预措施的知情同意：问题、病因和解决方案。
Eur J Cardiothorac Surg. 2011 Jun;39(6):912-7. doi: 10.1016/j.ejcts.2010.08.033. Epub 2010 Oct 8.
8
Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART).随机对照试验比较双侧与单根内乳动脉冠状动脉旁路移植术：动脉重建试验（ART）的 1 年结果。
Eur Heart J. 2010 Oct;31(20):2470-81. doi: 10.1093/eurheartj/ehq318. Epub 2010 Aug 30.
9
Adherence of catheterization laboratory cardiologists to American College of Cardiology/American Heart Association guidelines for percutaneous coronary interventions and coronary artery bypass graft surgery: what happens in actual practice?经皮冠状动脉介入治疗和冠状动脉旁路移植术的导管室心脏病专家对美国心脏病学会/美国心脏协会指南的依从性：实际实践中会发生什么？
Circulation. 2010 Jan 19;121(2):267-75. doi: 10.1161/CIRCULATIONAHA.109.887539. Epub 2010 Jan 4.
10
Get with the guidelines: a new chapter?
Circulation. 2010 Jan 19;121(2):194-6. doi: 10.1161/CIRCULATIONAHA.109.913756. Epub 2010 Jan 4.
Zotero 插件